NDC 002
Alternative Names: NDC-002Latest Information Update: 03 Jan 2024
At a glance
- Originator DR.NOAH Biotech
- Class Drug conjugates; Vascular disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Stroke
Most Recent Events
- 15 Mar 2023 Dr. Noah Biotech completes a phase I trial in Stroke in South Korea (PO, Tablet) (NCT06090474)
- 12 Jan 2023 Phase-I clinical trials in Stroke in South Korea (PO) (NCT06090474)
- 22 Jul 2021 Dr. Noah Biotech files an IND application with the Korea Food and Drug Administration (KFDA) in South Korea for Stroke